OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A population physiologically‐based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximab
Hsuan‐Ping Chang, Valentina Shakhnovich, Adam Frymoyer, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 1, pp. 290-302
Open Access | Times Cited: 8
Hsuan‐Ping Chang, Valentina Shakhnovich, Adam Frymoyer, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 1, pp. 290-302
Open Access | Times Cited: 8
Showing 8 citing articles:
Physiologically Based Pharmacokinetic Models for Infliximab, Ipilimumab, and Nivolumab Developed with GastroPlus to Predict Hepatic Concentrations
C Díez Vallejo, Cameron Meaney, Lara Clemens, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 372-372
Open Access
C Díez Vallejo, Cameron Meaney, Lara Clemens, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 372-372
Open Access
Opportunities and Challenges for PBPK Model of mAbs in Paediatrics and Pregnancy
Katherine L. Gill, Hannah M. Jones
The AAPS Journal (2022) Vol. 24, Iss. 4
Open Access | Times Cited: 12
Katherine L. Gill, Hannah M. Jones
The AAPS Journal (2022) Vol. 24, Iss. 4
Open Access | Times Cited: 12
Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars
Zvonimir Petrić, João Gonçalves, Paulo Paixão
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1766-1766
Open Access | Times Cited: 12
Zvonimir Petrić, João Gonçalves, Paulo Paixão
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1766-1766
Open Access | Times Cited: 12
Physiologically based pharmacokinetic modelling of semaglutide in children and adolescents with healthy and obese body weights
Thayná Rocco Machado, Thiago da Silva Honório, Thaisa Francielle Souza Domingos, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 10, pp. 3175-3194
Closed Access | Times Cited: 4
Thayná Rocco Machado, Thiago da Silva Honório, Thaisa Francielle Souza Domingos, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 10, pp. 3175-3194
Closed Access | Times Cited: 4
Mathematical Models to Characterize the Absorption, Distribution, Metabolism, and Excretion of Protein Therapeutics
Shufang Liu, Dhaval K. Shah
Drug Metabolism and Disposition (2022) Vol. 50, Iss. 6, pp. 867-878
Open Access | Times Cited: 4
Shufang Liu, Dhaval K. Shah
Drug Metabolism and Disposition (2022) Vol. 50, Iss. 6, pp. 867-878
Open Access | Times Cited: 4
Outcomes in Adult Inflammatory Bowel Disease Clinical Trials: Assessment of Similarity Among Participants with Adolescent-onset and Adult-onset Disease
Joel R. Rosh, Dan Turner, Jeffrey S. Hyams, et al.
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. 8, pp. 1250-1260
Closed Access
Joel R. Rosh, Dan Turner, Jeffrey S. Hyams, et al.
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. 8, pp. 1250-1260
Closed Access
Novel pharmacological developments in the management of paediatric inflammatory bowel disease
Zubin Grover, Andrew S. Day
Journal of Paediatrics and Child Health (2024) Vol. 60, Iss. 6, pp. 162-163
Open Access
Zubin Grover, Andrew S. Day
Journal of Paediatrics and Child Health (2024) Vol. 60, Iss. 6, pp. 162-163
Open Access
Application of physiologically based pharmacokinetic models for therapeutic proteins and other novel modalities
Rachel H. Rose, Armin Sepp, Felix Stader, et al.
Xenobiotica (2022) Vol. 52, Iss. 8, pp. 840-854
Closed Access | Times Cited: 3
Rachel H. Rose, Armin Sepp, Felix Stader, et al.
Xenobiotica (2022) Vol. 52, Iss. 8, pp. 840-854
Closed Access | Times Cited: 3
